Navigation Links
FASEB announces new client: The Histochemical Society
Date:9/15/2011

Bethesda, MD The Federation of American Societies for Experimental Biology (FASEB) announced today the signing of its newest client, the Histochemical Society (HCS). The executive leadership has retained FASEB to provide association management services to include general management support, membership marketing, recruitment, and retention, as well as a website redesign project. The Executive Director of HCS, William Stahl, PhD commented, "HCS is pleased to have FASEB's assistance with managing the society and our membership. We expect our partnership to provide additional benefits to our members and to the growth of our society."

As part of its services, FASEB will process all membership services for HCS while working with the Executive Director to engage and grow its current membership and prospective members. Additionally, FASEB will redesign and relaunch http://histochemicalsociety.org later this year. Jennifer Pesanelli, FASEB's Deputy Executive Director of Business Development shares Dr. Stahl's enthusiasm, "Our client services group is thrilled to support the growth strategies of HCS. We look forward to helping them enhance their society and expand their audience."

The HCS was founded in 1950 and consists of approximately 300 professional members including international representation. In terms of mission, The HCS is a scientific society dedicated to the development and application of new technologies in molecular pathology and cell biology and to the education of scientists in the use of these technologies to investigate normal and diseased cells and tissues.


'/>"/>

Contact: Stefan Bradham
sbradham@faseb.org
301-634-7213
Federation of American Societies for Experimental Biology
Source:Eurekalert

Page: 1

Related biology news :

1. FASEB MARC program announces the travel award recipients for the 2011 Leadership Development and Grant Writing Seminar for graduate students, postdoctoral fellows and new assistant professors
2. FASEB 2012 Excellence in Science Award recipient announced
3. FASEB announces new client: The International Conference on Human Immunity to Tuberculosis
4. FASEB president Dr. William T. Talman, testifies on behalf of increased funding for the National Science Foundation
5. FASEB announces the 2011 Summer Research Conference series: Registration is now open
6. FASEB praises President Obama for increasing funding for research in his FY 2012 budget
7. FASEB alert generates messages urging Congress to provide billion dollar increase for NIH
8. FASEB Scientists Descend on Capitol Hill to Advocate for Increased Science Funding
9. FASEB Scientists Descend on Capitol Hill to Advocate for Increased Science Funding
10. MedNet Solutions Announces the Latest Release of iMedNet EDC
11. Trudeau Institute announces new discovery in battle against infections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)... ivWatch LLC , a medical device company focused on improving the ... its ISO 13485 Certification, the global standard for medical device quality ... ... device for the early detection of IV infiltrations. ... "This is an important milestone for ivWatch, as it validates ...
(Date:6/14/2017)... IBM ) is introducing several innovative partner startups at ... between startups and global businesses, taking place in ... startups will showcase the solutions they have built with IBM ... France is one of the most ... increase in the number of startups created between 2012 and ...
(Date:5/6/2017)... 2017 RAM Group , Singaporean ... breakthrough in biometric authentication based on a ... to perform biometric authentication. These new sensors are based ... by Ram Group and its partners. This sensor will ... chains and security. Ram Group is a next ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... YORBA LINDA, CA (PRWEB) , ... October 11, ... ... adapted to upregulate any gene in its endogenous context, enabling overexpression experiments and ... activation (CRISPRa) system with small RNA guides is transformative for performing systematic gain-of-function ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 /PRNewswire/ ... London (ICR) and University of ... tool to risk-stratify patients with multiple myeloma (MM), in a ... . The University of Leeds is ... Myeloma UK, and ICR will perform the testing services to ...
(Date:10/10/2017)... (PRWEB) , ... October 10, ... ... development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed ... targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with ...
(Date:10/10/2017)... , ... October 10, 2017 , ... ... and business process optimization firm for the life sciences and healthcare industries, announces ... conference in San Francisco. , The presentation, “Automating GxP Validation for Agile Cloud ...
Breaking Biology Technology: